NEW YORK (GenomeWeb) – Having recently closed a $38 million Series A financing, startup Alveo Technologies plans to use the funding to commercialize its infectious disease diagnostic platform.
The company's infectious disease panels can simultaneously detect multiple different viral pathogens at a low cost, with the ability to easily scale up to 100 microreactors to find subtypes of certain diseases.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try 360Dx Premium now.
You may already have institutional access!
Check if I qualify.
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
